MURRIETA, CA--(Marketwire - April 21, 2008) - CLX Investment Company, Inc. (OTCBB: CLXN), which owns 51% of Zonda, Incorporated, a developer and manufacturer of unique diagnostic tests for the medical and non-medical markets, today announced that the company has begun operating under its new corporate name, CLX Medical, Inc.
